However, preclinical murine models of colitis and clinical CRC data have shown that the γδT17 cell subset, producing the IL-17A or IL-17F cytokines, promotes tumor progression through the accumulation of myeloid-derived suppressive cells (MDSC) (17, 18). Here, IL17A is linked to colorectal carcinoma.